BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 26178025)

  • 1. Genistein and cancer: current status, challenges, and future directions.
    Spagnuolo C; Russo GL; Orhan IE; Habtemariam S; Daglia M; Sureda A; Nabavi SF; Devi KP; Loizzo MR; Tundis R; Nabavi SM
    Adv Nutr; 2015 Jul; 6(4):408-19. PubMed ID: 26178025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy isoflavones and cancer prevention.
    Sarkar FH; Li Y
    Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-targeted therapy of cancer by genistein.
    Banerjee S; Li Y; Wang Z; Sarkar FH
    Cancer Lett; 2008 Oct; 269(2):226-42. PubMed ID: 18492603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
    Park OJ; Surh YJ
    Toxicol Lett; 2004 Apr; 150(1):43-56. PubMed ID: 15068824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line.
    Li Y; Ellis KL; Ali S; El-Rayes BF; Nedeljkovic-Kurepa A; Kucuk O; Philip PA; Sarkar FH
    Pancreas; 2004 May; 28(4):e90-5. PubMed ID: 15097869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
    Singh AV; Franke AA; Blackburn GL; Zhou JR
    Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cancer chemoprevention by soy isoflavone genistein.
    Sarkar FH; Li Y
    Cancer Metastasis Rev; 2002; 21(3-4):265-80. PubMed ID: 12549765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B; Li Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
    Mahmoud AM; Yang W; Bosland MC
    J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S; Zhang Y; Ali S; Bhuiyan M; Wang Z; Chiao PJ; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2005 Oct; 65(19):9064-72. PubMed ID: 16204081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy.
    Sarkar FH; Adsule S; Padhye S; Kulkarni S; Li Y
    Mini Rev Med Chem; 2006 Apr; 6(4):401-7. PubMed ID: 16613577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention.
    Neergheen VS; Bahorun T; Taylor EW; Jen LS; Aruoma OI
    Toxicology; 2010 Dec; 278(2):229-41. PubMed ID: 19850100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M; Osborne M; Telang NT
    Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.
    Whitsett TG; Lamartiniere CA
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1699-706. PubMed ID: 17181483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer therapeutic potential of soy isoflavone, genistein.
    Ravindranath MH; Muthugounder S; Presser N; Viswanathan S
    Adv Exp Med Biol; 2004; 546():121-65. PubMed ID: 15584372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
    Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
    Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
    Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular approaches toward targeted cancer prevention with some food plants and their products: inflammatory and other signal pathways.
    Khuda-Bukhsh AR; Das S; Saha SK
    Nutr Cancer; 2014; 66(2):194-205. PubMed ID: 24377653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.